Nov 14, 20242024/Q33.000M / ----
May 14, 20242024/Q12.000M / ----
Nov 13, 20232023/Q3303.000M / ----
--------
--------
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Liberty Live-C
LLYVK
5
American Express
AXP
JP Stock MarketDetailed Quotes
4893 Noile-Immune Biotech
- 141
- -2-1.40%
20min DelayTrading May 8 13:17 JST
6.11BMarket Cap-6.33P/E (Static)
143High139Low46.70KVolume143Open143Pre Close6.57MTurnover35352wk High0.31%Turnover Ratio43.30MShares12052wk Low-22.28EPS TTM2.13BFloat Cap775Historical HighLossP/E (Static)15.12MShs Float120Historical Low-22.28EPS LYR2.80%Amplitude--Dividend TTM1.29P/B100Lot Size--Div YieldTTM
Noile-Immune Biotech Key Stats
Noile-Immune Biotech Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Noile-Immune Biotech Earnings Reports
Read more
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting